VVOS - Vivos Therapeutics Inc. (VVOS) CEO Kirk Huntsman on Q3 2021 Results - Earnings Call Transcript
Vivos Therapeutics, Inc. (VVOS) Q3 2021 Results Conference Call November 15, 2021 5:00 PM ET Company Participants Edward Loew - IR Kirk Huntsman - CEO Brad Amman - CFO Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Scott Henry - ROTH Capital Presentation Operator Good day, everyone, and welcome to the Vivos Therapeutics Inc. Third Quarter 2021 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow management's remarks. This conference call is being recorded and a replay of today's call will be available on the Investor Relations section of the Vivos’ website and will remain posted there for the next 30 days. I will now hand the call over to Mr. Edward Loew, Vivos' Investor Relations Officer for introductions and the reading of the safe harbor statement. Please go ahead, sir. Edward Loew Thank you, operator. Hello, everyone, and welcome to
For further details see:
Vivos Therapeutics, Inc. (VVOS) CEO Kirk Huntsman on Q3 2021 Results - Earnings Call Transcript